Amit Hasija's most recent trade in Milestone Pharmaceuticals Inc was a trade of 204,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 204,000 | 204,000 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 204,000 | 204,000 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 136,000 | 136,000 | - | - | Restricted Stock Unit | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 100,000 | 150,000 (0%) | 0% | - | Common Shares | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 12 Dec 2025 | 58,007 | 91,993 (0%) | 0% | 2.3 | 134,576 | Common Shares |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,100 | 60,300 | - | - | Restricted Stock Units | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,100 | 112,093 (0%) | 0% | - | Common Shares | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Sale of securities on an exchange or to another person at price $ 1.93 per share. | 12 Dec 2025 | 12,245 | 99,848 (0%) | 0% | 1.9 | 23,633 | Common Shares |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 50,000 | 50,000 (0%) | 0% | - | Common Shares | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 50,000 | 50,000 | - | - | Series A Common Warrants (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 50,000 | 50,000 | - | - | Series B Common Warrants (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 175,000 | 175,000 | - | - | Employee Stock Option Grant (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 240,000 | 240,000 | - | - | Employee Stock Option (right to buy) |